QZW
- Product code
- QZW
- Device name
- Over-The-Counter Device To Assess Risk Of Sleep Apnea
- Device class
- Class 2
- 21 CFR
- 21 CFR 868.2378
- Medical specialty
- Anesthesiology
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 3
- Summaries archived here
- 2 (direct download)
- 510(k) clearances (all years, FDA)
- 3 (all years; only the last 3 years are listed here)
FDA classification definition
An over-the-counter device to assess risk of sleep apnea is intended to provide a notification of the risk of sleep apnea in users who have not been previously diagnosed with sleep apnea. This device uses software algorithms to analyze input sensor signals and provide a risk assessment for sleep apnea. It is not intended to provide a standalone diagnosis, replace traditional methods of diagnosis (e.g., polysomnography), assist clinicians in diagnosing sleep disorders, or be used as an apnea monitor.
510(k) clearances, last 3 years (3)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K261011 | 2026-07-20 | Samsung Electronics Co., Ltd. | Sleep Apnea Feature (v2.0) | |
| K240929 | 2024-09-13 | Apple, Inc. | Sleep Apnea Notification Feature (SANF) | |
| DEN230041 | 2024-02-06 | Samsung Electronics Co., Ltd. | Sleep Apnea Feature | — |
Official FDA classification page: QZW
Classification and pathway per current FDA publications. Data from openFDA (CC0).